HKMPY - Hikma Pharmaceuticals PLC

Other OTC - Other OTC Delayed price. Currency in USD
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
270,000
426,000
323,000
442,000
Other short-term investments
22,000
24,000
24,000
23,000
Total cash
270,000
426,000
323,000
442,000
Net receivables
777,000
781,000
662,000
637,000
Inventory
776,000
695,000
757,000
568,000
Other current assets
110,000
97,000
46,000
39,000
Total current assets
1,999,000
2,094,000
1,922,000
1,848,000
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
2,008,000
1,146,000
1,068,000
962,000
Accumulated depreciation
-927,000
-809,000
-773,000
-728,000
Net property, plant and equipment
1,081,000
1,146,000
1,068,000
962,000
Goodwill
389,000
285,000
289,000
282,000
Intangible assets
735,000
607,000
587,000
552,000
Other long-term assets
23,000
11,000
14,000
14,000
Total non-current assets
2,472,000
2,278,000
2,213,000
2,082,000
Total assets
4,471,000
4,372,000
4,135,000
3,930,000
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
139,000
112,000
158,000
569,000
Accounts payable
291,000
262,000
470,000
473,000
Other current liabilities
348,000
339,000
290,000
315,000
Total current liabilities
1,077,000
1,016,000
1,028,000
1,471,000
Non-current liabilities
Long-term debt
1,074,000
651,000
692,000
48,000
Deferred tax liabilities
19,000
24,000
31,000
20,000
Other long-term liabilities
92,000
140,000
164,000
203,000
Total non-current liabilities
1,246,000
889,000
959,000
330,000
Total liabilities
2,323,000
1,905,000
1,987,000
1,801,000
Stockholders' equity
Common stock
40,000
42,000
41,000
41,000
Retained earnings
2,092,000
2,189,000
1,892,000
1,973,000
Total stockholders' equity
2,135,000
2,453,000
2,135,000
2,117,000
Total liabilities and stockholders' equity
4,471,000
4,372,000
4,135,000
3,930,000